Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2010
Visfatin levels in female, morbid, nondiabetic obese patients after biliopancreatic diversion surgery.
Сравнительное исследованиеСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
de Luis Daniel Antonio, Izaola Olatz, Conde Rosa, Primo David, Sagrado Manuel González, Aller Rocio
Аннотация
BACKGROUND: Visfatin was recently identified as a protein preferentially expressed in visceral adipose tissue. The purpose of the present study was to investigate the changes in serum visfatin levels after biliopancreatic diversion and the association of the changes observed with other parameters in morbidly nondiabetic obese women.
METHODS: A sample of 27 morbidly obese women (body mass index >40 kg/m(2)) were operated. The biochemical and anthropometric parameters were measured at the initial visit and 1 year after surgery. The frequency of patients with hypertension and hyperlipidemia was recorded at 1 year.
RESULTS: The mean patient age was 46.0 ± 13.0 years, and the mean preoperative body mass index was 46.3 ± 13.1 kg/m(2). The body mass index, weight, waist circumference, fat mass, blood pressure, total cholesterol, and low-density lipoprotein cholesterol had decreased significantly. The visfatin levels did not change after surgery (5.70 ± 1.84 ng/mL versus 6.12 ± 1.68 ng/mL; P = NS). The correlation analysis showed a positive association between the baseline visfatin and total cholesterol level (r = 0.49; P <.01).
CONCLUSION: The massive weight reduction 1 year after biliopancreatic diversion was not associated with a significant change in the circulating visfatin levels in morbidly obese women.
METHODS: A sample of 27 morbidly obese women (body mass index >40 kg/m(2)) were operated. The biochemical and anthropometric parameters were measured at the initial visit and 1 year after surgery. The frequency of patients with hypertension and hyperlipidemia was recorded at 1 year.
RESULTS: The mean patient age was 46.0 ± 13.0 years, and the mean preoperative body mass index was 46.3 ± 13.1 kg/m(2). The body mass index, weight, waist circumference, fat mass, blood pressure, total cholesterol, and low-density lipoprotein cholesterol had decreased significantly. The visfatin levels did not change after surgery (5.70 ± 1.84 ng/mL versus 6.12 ± 1.68 ng/mL; P = NS). The correlation analysis showed a positive association between the baseline visfatin and total cholesterol level (r = 0.49; P <.01).
CONCLUSION: The massive weight reduction 1 year after biliopancreatic diversion was not associated with a significant change in the circulating visfatin levels in morbidly obese women.
Предметные рубрики MeSH
Biliopancreatic DiversionBiomarkersBody Mass IndexDiabetes MellitusDisease ProgressionEnzyme-Linked Immunosorbent AssayFemaleFollow-Up StudiesHumansIntra-Abdominal FatMiddle AgedNicotinamide PhosphoribosyltransferaseObesity, MorbidPostoperative PeriodProspective StudiesSeverity of Illness IndexTime Factors